DENTIS Co., Ltd. ( CEO Ki-bong Shim ) , an implant-based dental and medical solution company, has obtained sales approval from the U.S. Food and Drug Administration (FDA) for its self-developed resonance frequency analysis (RFA) dental implant high-precision measuring device , 'ChecQ ' .
The dental implant fixation measuring device is used to easily measure the degree of implant osseointegration and fixation . The measuring method is largely divided into the percussion method and the RFA method . The RFA method is a next-generation technology that can complement stability and error problems caused by percussion strength . The Dentis Medical Device Research Institute has succeeded in developing the dental implant fixation measuring device that uses the RFA method for the first time in Korea and the third in the world with its own technology .
Dentis' CheckQ has received great attention in the domestic market since its launch in July of last year , and with this FDA approval, it is expected to accelerate its entry into the global market . The company is currently also preparing for the European CE MDR for CheckQ .
DENTIS is preparing for consecutive CE-MDR certifications for its flagship and core dental equipment, including ▲ CheckQ, ▲ dental unit chair ' LUVIS CHAIR', ▲ painless anesthesia machine ' DENOPS', and ▲ Korea's first portable intraosseous anesthesia machine ' DENOPS – I' within the first half of this year , and its strategy is to further increase global market growth in the second half of the year as soon as all preparations are completed in the first half .
A Dentis official said, “ Since last year, Dentis’s excellent technological prowess has been recognized in the global market through overseas approvals and approvals, such as FDA and CE , for major new products, ” and “ This year, starting with CheckQ, we will successfully push forward with preparations for expanding into the global market and achieve performance growth with aggressive sales strategies from overseas corporations in the U.S. and India . ”
one side Dentis is focusing on strengthening its overseas sales network to lead global new growth by announcing the establishment of new corporations in Thailand , Vietnam , Japan , Poland, following the U.S. , China , Spain , Portugal , Malaysia , and India . The company's global growth potential is expected to be strengthened through the continuous overseas approvals for its main new products and active sales activities through its corporations .
- See more related articles
You must be logged in to post a comment.